Nutritional and gibberellic acid requirements in kiwifruit vitroponic cultures
- 作者Paloma Moncaleán; M. Jesús Cañal; Helena Fernández; Belén Fernández; Ana Rodríguez
- 卷第39卷
- 期第1期
- 文件大小167.96KB
- 发表时间2003-0102
- DOI10.1079/ivp2002371
- 页码49-55
Radiotherapy Combined with Transcatheter Arterial Infusion Chemotherapy for Locally Advanced Cervical CancerMasaki Kokubo, Kazushige Tsutsui, Y, · Acta Oncologica · 1998
Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancerJ.H Maduro; E Pras; P.H.B Willemse; E.G.E de Vries · 2003
Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinomaTchan-Kyu Park; Ja-Young Kwon; Sang-Wun Kim; Sung-Hoon Kim; Soo-Nyung Kim; Gwi Eon Kim · 2004
Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reportsShoji, Tadahiro; Takeshita, Ryosuke; Mukaida, Rika; Takatori, Eriko; Nagasawa, Takayuki; Omi, Hideo; Sugiyama, Toru · Molecular and Clinical Oncology · 2018
Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical studyShen Qian,Ling Ye,Yun-Hong Tian,Li-Gen Wang,Zuo-Ping Huang… · Chinese Journal of Cancer · 2017
Extended-Field Radiotherapy and High-Dose Brachytherapy With Combined Platinum-Based Chemotherapy for Cervical Cancer With Para-Aortic Lymph Node InvolvementS. Lee; K. Lee; J. Choi; K. Lee; J. Shin; C. Park · 2007
59 LONG-TERM TOXICITY FOLLOWING DEFINITIVE RADIOTHERAPY TO PELVIS OR PELVIS AND PARAAORTIC LYMPH NODES IN COMBINATION WITH CONCURRENT CHEMOTHERAPY FOR CERVICAL CANCER PATIENTSYan, J.; Fyles, A.; Pintile, M.; Kelly, V.; Manchul, L.; Levin, W.; Milosevic, M. · Radiotherapy and Oncology · 2009
Optimized low dose rate pellet configurations for intravaginal brachytherapyRon S. Sloboda; Robert G. Pearcey; Sandra J. Gillan · 1993
mtDNA mutations in invasive cervix tumors: A retrospective analysisJoan Allalunis-Turner; Ivy Ma; John Hanson; Robert G. Pearcey · 2006
Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell linesRichard A. Britten; Andrew J. Evans; M.Joan Allalunis-Turner; Robert G. Pearcey · 1996
The importance of hemoglobin levels during radiotherapy for carcinoma of the cervixMichelle Grogan; Gillian M. Thomas; Iris Melamed; Frances L. W. Wong; Robert G. Pearcey; Paul K. Joseph; Lorraine Portelance; Juanita Crook; Keith D. Jones · 1999
The management of inoperable Stage I endometrial cancer using intracavitary brachytherapy alone: A 20-year institutional reviewCarey B. Shenfield; Robert G. Pearcey; Sunita Ghosh; George S. Dundas · 2009
Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivorsKerry S. Courneya; Kristina H. Karvinen; Kristin L. Campbell; Robert G. Pearcey; George Dundas; Valerie Capstick; Katia S. Tonkin · 2005
Phase II Study to Evaluate the Toxicity and Efficacy of Concurrent Cisplatin and Radiation Therapy in the Treatment of Patients with Locally Advanced Squamous Cell Carcinoma of the CervixRobert G. Pearcey; Gavin C.E. Stuart; Grant D. MacLean; Jill G. Nation; Keith Arthur; Himu Lukka; John Jeffrey; Keith James; Michael Brundage · 1995